← Leaderboards
Mahmoud A Ghannoum
Case Western Reserve University
$11,503,516
Attributed
$13,221,805
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,221,805 · 8
By mechanism
R01$12,781,284 · 6
R21$440,521 · 1
P30$0 · 1
Top collaborators
- Pranab Kumar Mukherjee4 shared
- Thomas S Mccormick3 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Pranab Kumar Mukherjee$1,656,000
- Thomas S McCormick$4,069,015
- Luca Di Martino$610,350
Others in their field
Top investigators on “Candida Albicans”
- Alexander D Johnson · University Of California San Francisco$23,545,370
- Aaron P Mitchell · La Biomed Res Inst/ Harbor Ucla Med Ctr$20,872,115
- Gavin J Sherlock · Stanford University$18,218,461
- Jay B Jackson · Johns Hopkins University$17,529,470
- Scott G Filler · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center$14,524,347
- Gerald R Fink · Whitehead Institute For Biomedical Res$14,278,186
Research focus
Candida AlbicansIn VivoInfectionCandidaIn VitroOralTissuesExhibitsYeastsInsightMicrobial BiofilmsProductionAntifungal AgentsCandidiasisFungusGenesMucous MembraneMutantPlayAffectPreventionPathogenesisPhenotypeGene Expression
Grant awards (35)
Development and evaluation of a second-generation fungerp for systemic and cutaneous C. auris infection$648,567
R01 · FY2025 · AI · contact PI
Development and evaluation of a second-generation fungerp for systemic and cutaneous C. auris infection$648,567
R01 · FY2024 · AI · contact PI
Polymicrobial interactions in Crohn's Disease$617,403
R01 · FY2023 · AI · contact PI
Development and evaluation of a second-generation fungerp for systemic and cutaneous C. auris infection$554,444
R01 · FY2023 · AI · contact PI
Polymicrobial interactions in Crohn's Disease$617,403
R01 · FY2022 · AI · contact PI
Polymicrobial interactions in Crohn's Disease$617,403
R01 · FY2021 · AI · contact PI
Polymicrobial interactions in Crohn's Disease$617,403
R01 · FY2020 · AI · contact PI
Identification of effective SCY-078 analogues targeting C. auris$200,521
R21 · FY2020 · AI · contact PI
Polymicrobial interactions in Crohn's Disease$627,568
R01 · FY2019 · AI · contact PI
Identification of effective SCY-078 analogues targeting C. auris$240,000
R21 · FY2019 · AI · contact PI
Mechanism of antifungal action of Pichia proteins$396,250
R01 · FY2018 · DE · contact PI
Mechanism of antifungal action of Pichia proteins$396,250
R01 · FY2017 · DE · contact PI
Mechanism of antifungal action of Pichia proteins$396,250
R01 · FY2016 · DE · contact PI
Mechanism of antifungal action of Pichia proteins$396,250
R01 · FY2015 · DE · contact PI
Mechanism of antifungal action of Pichia proteins$396,250
R01 · FY2014 · DE · contact PI
Identification of early phase C. albicans biofilm proteins$350,820
R01 · FY2011 · DE · contact PI
Identification of early phase C. albicans biofilm proteins$361,687
R01 · FY2010 · DE · contact PI
Identification of early phase C. albicans biofilm proteins$367,138
R01 · FY2009 · DE · contact PI
MECHANISM OF IL-12 INHIBITION BY CANDIDA ALBICANS$320,211
R01 · FY2009 · AI · contact PI
Identification of early phase C. albicans biofilm proteins$371,022
R01 · FY2008 · DE · contact PI
MECHANISM OF IL-12 INHIBITION BY CANDIDA ALBICANS$320,211
R01 · FY2008 · AI · contact PI
Identification of early phase C. albicans biofilm proteins$388,382
R01 · FY2007 · DE · contact PI
MECHANISM OF IL-12 INHIBITION BY CANDIDA ALBICANS$326,412
R01 · FY2007 · AI · contact PI
MECHANISM OF IL-12 INHIBITION BY CANDIDA ALBICANS$336,161
R01 · FY2006 · AI · contact PI
MECHANISM OF IL-12 INHIBITION BY CANDIDA ALBICANS$344,250
R01 · FY2005 · AI
Biology and Drug Resistance of Candida Biofilms$343,057
R01 · FY2005 · DE
Biology and Drug Resistance of Candida Biofilms$343,057
R01 · FY2004 · DE
Biology and Drug Resistance of Candida Biofilms$343,057
R01 · FY2003 · DE
PHOSPHOLIPASE B--MECHANISMS AUGMENTING CANDIDA VIRULENCE$253,229
R01 · FY2003 · AI
Biology and Drug Resistance of Candida Biofilms$366,307
R01 · FY2002 · DE
PHOSPHOLIPASE B--MECHANISMS AUGMENTING CANDIDA VIRULENCE$245,850
R01 · FY2002 · AI
Pilot--IL-12 inhibition of Candida albicans$0
P30 · FY2002 · AR
PHOSPHOLIPASE B--MECHANISMS AUGMENTING CANDIDA VIRULENCE$238,689
R01 · FY2001 · AI
Pilot--IL-12 inhibition of Candida albicans$0
P30 · FY2001 · AR
PHOSPHOLIPASE B--MECHANISMS AUGMENTING CANDIDA VIRULENCE$231,736
R01 · FY2000 · AI